Now on MSN Money: Improved chart, quote and data pages, powered by Morningstar. Learn what’s new.

Novelos Therapeutics

(PINX: NVLT)
  • Trade now
  • Add to Watchlist
  • Get Chart
  • Print report
0.44 Up unch unch
Find financial results for:
MORE ON NVLT
 Annual  Interim
2012 2011 2010 2009 2008
Period End Date 12/31/2012 12/31/2011 12/31/2010 12/31/2009 12/31/2008
Stmt Source N/A 10-K 10-K 10-K 10-K
Stmt Source Date 12/31/2012 03/28/2013 03/09/2012 04/14/2011 03/30/2010
Stmt Update Type Original Updated Updated Updated Updated
Currency Code USD USD USD USD USD
 
Total Revenue 0.0 0.0 0.0 0.1 0.1
           
Gross Profit 0.0 0.0 0.0 0.1 0.1
           
Selling,General and Administrative
3.6 2.7 1.2 2.2 2.2
General and Administrative Expense 3.6 2.7 1.2 2.2 2.2
Research and Development 5.1 3.6 3.0 8.1 14.5
Special Income/Charges 0.0 0.7 0.1 0.0 0.0
Operating Expenses 8.8 7.0 4.2 10.3 16.7
 
Operating Income -8.8 -7.0 -4.2 -10.2 -16.6
           
Net Interest Income 0.0 -0.2 -0.6 0.0 0.1
Other Income/Expense,Net 0.0 -0.2 0.2 -12.0 0.0
Pretax Income -8.8 -7.4 0.0 0.0 0.0
           
Net Income -8.8 -7.4 -4.6 -22.3 -16.5
 
Tax Rate 0.000000 0.000000 0.000000 0.000000 0.000000
 
Basic EPS
-0.23 -0.31 -0.36 -81.09 -85.68
Basic Weighted Average Shares 41.12 23.96 12.82 0.33 0.27
Basic EPS from Continuing Operations -0.23 -0.31 -0.36 -81.09 -85.68
Basic EPS,Continuing and Discontinued -0.23 -0.31 -0.36 -81.09 -85.68
Diluted EPS
-0.23 -0.31 -0.36 -81.09 -85.68
Diluted Weighted Average Shares 41.12 23.96 12.82 0.33 0.27
Diluted EPS from Continuing Operations -0.23 -0.31 -0.36 -81.09 -85.68
Diluted EPS,Continuing and Discontinued -0.23 -0.31 -0.36 -81.09 -85.68
 

Financial data in USD
Values in Millions (Except for per share items)

Business Type: Industry

Financial statements are prepared in this standard format to allow direct comparisons of all companies and industries across multiple time frames.

See 10K and 10Q SEC Filings for as reported statements

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.